PL1924244T3 - Kierowany polem magnetycznym transfer substancji czynnej dla terapii aerozolowej - Google Patents
Kierowany polem magnetycznym transfer substancji czynnej dla terapii aerozolowejInfo
- Publication number
- PL1924244T3 PL1924244T3 PL06791666T PL06791666T PL1924244T3 PL 1924244 T3 PL1924244 T3 PL 1924244T3 PL 06791666 T PL06791666 T PL 06791666T PL 06791666 T PL06791666 T PL 06791666T PL 1924244 T3 PL1924244 T3 PL 1924244T3
- Authority
- PL
- Poland
- Prior art keywords
- magnetic
- active substance
- aerosol therapy
- substance transfer
- field controlled
- Prior art date
Links
- 239000000443 aerosol Substances 0.000 title abstract 5
- 239000013543 active substance Substances 0.000 title abstract 3
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 239000006249 magnetic particle Substances 0.000 abstract 3
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005042768A DE102005042768A1 (de) | 2005-09-08 | 2005-09-08 | Magnetfeld-gesteuerter Wirkstofftransfer für die Aerosoltherapie |
| PCT/EP2006/008357 WO2007028512A2 (de) | 2005-09-08 | 2006-08-25 | Magnetfeld-gesteuerter wirkstofftransfer für die aerosoltherapie |
| EP06791666A EP1924244B1 (de) | 2005-09-08 | 2006-08-25 | Magnetfeld-gesteuerter wirkstofftransfer für die aerosoltherapie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1924244T3 true PL1924244T3 (pl) | 2011-10-31 |
Family
ID=37762991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06791666T PL1924244T3 (pl) | 2005-09-08 | 2006-08-25 | Kierowany polem magnetycznym transfer substancji czynnej dla terapii aerozolowej |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8567410B2 (pl) |
| EP (1) | EP1924244B1 (pl) |
| AT (1) | ATE485811T1 (pl) |
| DE (2) | DE102005042768A1 (pl) |
| ES (1) | ES2355059T3 (pl) |
| PL (1) | PL1924244T3 (pl) |
| WO (1) | WO2007028512A2 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2777841C (en) | 2009-11-02 | 2017-01-17 | Francis M. Creighton | Magnetomotive stator system and methods for wireless control of magnetic rotors |
| EP2338520A1 (de) | 2009-12-21 | 2011-06-29 | Ludwig Maximilians Universität | Konjugat mit Zielfindungsligand und dessen Verwendung |
| EP2736052B1 (en) * | 2011-07-15 | 2018-05-30 | Beijing Gignano Biointerface Co. Ltd | A metal and metal oxide material having an organic surface modification and manufacturing method therefor |
| US9883878B2 (en) | 2012-05-15 | 2018-02-06 | Pulse Therapeutics, Inc. | Magnetic-based systems and methods for manipulation of magnetic particles |
| JP6208750B2 (ja) * | 2012-06-08 | 2017-10-04 | エスリス ゲーエムベーハーｅｔｈｒｉｓ ＧｍｂＨ | メッセンジャーｒｎａの肺送達 |
| WO2014150603A1 (en) * | 2013-03-15 | 2014-09-25 | Sri Radhakrishnan | Systems and methods for treatment using magnetic fields |
| US20150065821A1 (en) * | 2013-09-05 | 2015-03-05 | Google Inc. | Nanoparticle Phoresis |
| US9999380B1 (en) | 2014-09-22 | 2018-06-19 | Verily Life Sciences Llc | Segmented magnets |
| US10349870B1 (en) | 2014-09-22 | 2019-07-16 | Verily Life Sciences Llc | Magnetic switching |
| US10492709B2 (en) | 2015-11-19 | 2019-12-03 | Verily Life Sciences Llc | Magnetic probes for in vivo capture and detection of extracellular vesicles |
| US11013682B2 (en) | 2016-04-25 | 2021-05-25 | Technion Research & Development Foundation Limited | Targeted delivery of aerosols of magnetized active agents |
| EP4035659A1 (en) | 2016-11-29 | 2022-08-03 | PureTech LYT, Inc. | Exosomes for delivery of therapeutic agents |
| US10974022B2 (en) * | 2018-02-28 | 2021-04-13 | Gyrus Acmi, Inc. | Nasal implant assembly |
| US11918315B2 (en) | 2018-05-03 | 2024-03-05 | Pulse Therapeutics, Inc. | Determination of structure and traversal of occlusions using magnetic particles |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10020376A1 (de) | 2000-04-26 | 2001-11-08 | Inst Zelltechnologie E V | Dynamische Marker |
| US20020086842A1 (en) * | 2000-06-26 | 2002-07-04 | Christian Plank | Method for transfecting cells using a magnetic field |
| EP1496860A1 (en) | 2001-09-28 | 2005-01-19 | Saoirse Corporation | Localized non-invasive biological modulation system |
| US7189198B2 (en) * | 2002-07-03 | 2007-03-13 | Stereotaxis, Inc. | Magnetically guidable carriers and methods for the targeted magnetic delivery of substances in the body |
| DE10331439B3 (de) | 2003-07-10 | 2005-02-03 | Micromod Partikeltechnologie Gmbh | Magnetische Nanopartikel mit verbesserten Magneteigenschaften |
| GB0313259D0 (en) | 2003-06-09 | 2003-07-16 | Consejo Superior Investigacion | Magnetic nanoparticles |
| WO2004112799A1 (en) | 2003-06-13 | 2004-12-29 | Chrysalis Technologies Incorporated | Methods and apparatus for producing nanoscale particles |
| US7316817B2 (en) * | 2004-01-02 | 2008-01-08 | New Medical Technologies, Inc. | Method and device for topical delivery of therapeutic agents to the skin |
| EP1674128A1 (en) * | 2004-12-22 | 2006-06-28 | Steinbeis-Transferzentrum für Herz-Kreislaufforschung | Magnetic pole matrices useful for tissue engineering and treatment of disease |
| US20060142632A1 (en) * | 2004-12-29 | 2006-06-29 | Attila Meretei | Systems and methods for removing plaque from a blood vessel |
-
2005
- 2005-09-08 DE DE102005042768A patent/DE102005042768A1/de not_active Withdrawn
-
2006
- 2006-08-25 US US11/991,535 patent/US8567410B2/en active Active
- 2006-08-25 WO PCT/EP2006/008357 patent/WO2007028512A2/de active Application Filing
- 2006-08-25 ES ES06791666T patent/ES2355059T3/es active Active
- 2006-08-25 DE DE502006008194T patent/DE502006008194D1/de active Active
- 2006-08-25 AT AT06791666T patent/ATE485811T1/de active
- 2006-08-25 PL PL06791666T patent/PL1924244T3/pl unknown
- 2006-08-25 EP EP06791666A patent/EP1924244B1/de not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| US20090299127A1 (en) | 2009-12-03 |
| EP1924244B1 (de) | 2010-10-27 |
| WO2007028512A3 (de) | 2007-06-21 |
| EP1924244A2 (de) | 2008-05-28 |
| DE102005042768A1 (de) | 2007-03-15 |
| ES2355059T3 (es) | 2011-03-22 |
| DE502006008194D1 (de) | 2010-12-09 |
| US8567410B2 (en) | 2013-10-29 |
| ATE485811T1 (de) | 2010-11-15 |
| WO2007028512A2 (de) | 2007-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1924244T3 (pl) | Kierowany polem magnetycznym transfer substancji czynnej dla terapii aerozolowej | |
| IL163844A0 (en) | Pressurised metered dose inhalers containing solutions of beta-2 agonists | |
| TWI315203B (en) | Process for producing sterile suspensions of slightly soluble basic peptide complexes, sterile suspensions of slightly soluble basic peptide complexes, pharmaceutical formulations containing them, and the use thereof as medicaments | |
| IL186162A0 (en) | An aerosolized medicament containing amikacin and systems and devices for delivering the same | |
| IL174496A0 (en) | Aerosol formulation for inhalation, containing an anticholinergic agent | |
| HK1064295A1 (en) | Medical aerosol formulations | |
| EP1971372A4 (en) | COMPOSITIONS OF HYDROPHOBIC CORE CARRIERS FOR THE DELIVERY OF THERAPEUTIC AGENTS, AND METHODS OF PREPARATION AND USE | |
| TW200508214A (en) | Novel compounds | |
| EP1626746A4 (en) | LIQUID AEROSOL PREPARATIONS CONTAINING INSULIN AND AEROSOL GENERATING DEVICES AND METHODS FOR GENERATING INSULIN AS AEROSOL | |
| BRPI0509991A (pt) | aparelho de fornecimento em aerossol, métodos e composições para sistemas de respiração auxiliados por pressão | |
| EA200501586A1 (ru) | Фармацевтические продукты | |
| ZA200708304B (en) | Dipeptidyl Peptidase-IV inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent | |
| EP1635762A4 (en) | LOW DOSE INHALABLE PHARMACEUTICAL POWDERS | |
| EP1940459A4 (en) | SOLID SOLUTION SPREFORATOR WITH A MEDICAL PARTICLE AND / OR DRUG ADDED PARTICLES | |
| GEP20125469B (en) | Inhibitors of akt activity | |
| IL178595A0 (en) | 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents | |
| WO2007060104A3 (de) | Aerosolformulierung für die inhalation enthaltend ein anticholinergikum | |
| AU2003217950A8 (en) | Agglomerated particles for aerosol drug delivery | |
| IL181445A0 (en) | Use of (halobenzyloxy)benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium selective modulators | |
| IL195935A0 (en) | 18-methyl-19-nor-androst-4-en 17,17-spiroether (18-methyl-19-nor-20-spirox-4-en-3-one) and pharmaceutical preparations containing the same | |
| PL1954251T3 (pl) | Kompozycja o wydłużonym uwalnianiu soli żelaza jako aktywnego składnika, sposób jej otrzymywania i jej zastosowanie | |
| EP1602362A4 (en) | DRUG COMPOSITION COMPRISING AN ADHESIVE ACTIVE INGREDIENT IN HIGH CONCENTRATION TO A SPHERICAL CORE | |
| GB0328630D0 (en) | Metered dose inhalation preparations | |
| ZA200701443B (en) | Pharmaceutical composition in the form of a gastric-resident tablet containing an active principle | |
| TW200738635A (en) | New salt |